Mario Tiberi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Prefrontal Cortex

Inflammatory Response

Signaling Pathway

Top Venues

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher J Bergin, Aïcha Zouggar, Amanda Mendes da Silva, Tanguy Fenouil, Joshua R Haebe, Angelique N Masibag, Gautam Agrawal, Muhammad S Shah, Tamara Sandouka, Mario Tiberi, Rebecca A C Auer, Michele Ardolino, Yannick D Benoit
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors. Nature cancer 5 (3) (2024)
Christopher J Bergin, Aïcha Zouggar, Amanda Mendes da Silva, Tanguy Fenouil, Joshua R Haebe, Angelique N Masibag, Gautam Agrawal, Muhammad S Shah, Tamara Sandouka, Mario Tiberi, Rebecca A C Auer, Michele Ardolino, Yannick D Benoit
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors. Nature cancer 5 (3) (2024)
Christopher J Bergin, Aïcha Zouggar, Amanda Mendes da Silva, Tanguy Fenouil, Joshua R Haebe, Angelique N Masibag, Gautam Agrawal, Muhammad S Shah, Tamara Sandouka, Mario Tiberi, Rebecca A C Auer, Michele Ardolino, Yannick D Benoit
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors. Nature cancer (2024)
Khaled S Abd-Elrahman, Awatif Albaker, Jessica M de Souza, Fabíola Mara Ribeiro, Michael G Schlossmacher, Mario Tiberi, Alison Hamilton, Stephen S G Ferguson
Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner. Science signaling 13 (662) (2020)